Sentences with phrase «technology impact fund»

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Requiring the reduction of carbon emissions will make coal - based energy more costly, while solar and wind technology are expected to be priced more competitively, thereby supporting those alternative energy industries, says Jason Blumberg, chief executive and managing director of Energy Foundry, a Chicago - based cleantech impact venture capital fund.

Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

The International Monetary Fund believes distributed ledger technology can have a profound impact on the global economy.

About ArcTern Ventures ArcTern Ventures (www.arcternventures.com) is a North American venture capital fund with a focus on early stage investments in companies with breakthrough technologies that will positively impact the planet.

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.

Rep. Paul Tonko writes that federal funding has had a direct impact on technology such as Doppler radar, GPS and smartphones.

PETROSS is supported by the Advanced Research Projects Agency - Energy (ARPA - E), which funds initial research for high - impact energy technologies to show proof of concept before private - sector investment.

Because STEP grants are considered institutional grants, projects are more likely to be funded if the plan intends to boost the number of all science, technology, engineering, and mathematics graduates — thus, making a large impact — as opposed to targeting one discipline or underrepresented group.

Change is being driven from all sides, particularly through the impact of new technologies across the whole discovery and development process and from changes in the way that health care is funded and delivered.

Poll, head of technology for the British government — funded Omega Project, a division of Manchester Metropolitan University that partners with industry to study the environmental impact of aviation and offer possible solutions, pointed out the need for nonkerosene - powered aircraft «I think nuclear - powered airplanes are the answer beyond 2050,» he said, concluding, «If we want to continue to enjoy the benefits of air travel without hindrance from environmental concerns, we need to explore nuclear power.

Jim Thomas of the Ottawa - based ETC Group said the U.S. military's substantial funding of gene drive research «raises alarming question about this entire field,» and he called the technology «powerful and dangerous,» warning that it «could have disastrous impacts on peace, food security, and the environment.»

The gift will allow the Carney Institute to accelerate hiring of leading faculty and postdoctoral scholars in fields related to brain science, supply seed funding for high - impact new research, and also fund essential new equipment and infrastructure in technology - intensive areas of exploration.

STFC has recently awarded each of its top 22 universities an Impact Acceleration Account (IAA) to help accelerate impact derived from STFC - funded science and technImpact Acceleration Account (IAA) to help accelerate impact derived from STFC - funded science and technimpact derived from STFC - funded science and technology.

We can help schools get the right funding to make the switch to LED lighting and carefully plan the works, using the right quality technology as FortisDay presents, to have maximum impact.»

In «The Common Core Takes Hold,» Robert Rothman of the Alliance for Excellent Education acknowledges a number of McShane's concerns: states» shrinking budgets will likely impact the funding necessary for implementation; there is little to no quality monitoring of the new resources that are being created; the new assessments — and the technology required to implement them — are hugely expensive; the public at large is poorly informed and their support for the standards is waning; and a significant drop in student test scores following implementation of Common Core - aligned assessments is a real concern.

In recent years, the U.S. government has funded dozens of cluster - randomized trials that seek to evaluate the impact of science, technology, engineering and mathematics (STEM) curriculum materials and teacher professional development on student outcomes.

Launched in 2011, Project Leadership and Investment for Transformation, or L.I.F.T., is a five - year initiative in nine low - performing schools in Charlotte, North Carolina.35 The project focuses on innovative strategies to provide students with extended learning time and increased access to technology while supporting community engagement and excellent teaching.36 Project L.I.F.T. worked with Public Impact — a nonprofit organization that works with school districts to create innovative school models — to design hybrid teacher - leader roles that «extend the reach» of high - performing teachers to more students.37 These «multi-classroom leaders» continue to teach while leading teams of teachers and assuming responsibility for the learning of all students taught by their team.38 For this advanced role, teachers earn supplements of up to $ 23,000 annually, funded sustainably by reallocating funds within current budgets.39

Nevertheless, Committee members found the evidence on the impact of high - quality pre-K and third - grade reading so compelling that members recommended making difficult choices to prioritize these areas even at the potential expense of other K - 12 funding priorities, such as lowering class sizes, investing in teacher professional development, and improving classroom technology, that have not been shown to correlate as strongly with improved student outcomes, particularly for high - need students.

The evaluation of the North Carolina IMPACT project by the William and Ida Friday Institute for Educational Innovation at North Carolina State University focused, in part, on assessing teacher characteristics related to technology adoption before and after a 3 - year infusion of technology funding at 11 elementary and middle schools located in low - socioeconomic - status districts (No Child Left Behind Act of 2001).

The Principal Investigator (PI) or Co-PI on federally funded research and implementation projects, Sean is currently examining the impact of virtual reality and online learning on student development as well as ways to apply evidence - based technology innovations across the lives of those with exceptionalities, particularly in the area of literacy and technology.

In October 2015, the White House Office of Science and Technology Policy (OSTP) and the Office of Personnel Management (OPM) established an Interagency Policy Group to identify policies and practices to increase diversity in the science, technology, engineering, and mathematics (STEM) workforce both in the Federal Government and in federally - funded institutions of higher education, by reducing the impact of implicit and explicit bias in their respective recruitment, hiring, development and training Technology Policy (OSTP) and the Office of Personnel Management (OPM) established an Interagency Policy Group to identify policies and practices to increase diversity in the science, technology, engineering, and mathematics (STEM) workforce both in the Federal Government and in federally - funded institutions of higher education, by reducing the impact of implicit and explicit bias in their respective recruitment, hiring, development and training technology, engineering, and mathematics (STEM) workforce both in the Federal Government and in federally - funded institutions of higher education, by reducing the impact of implicit and explicit bias in their respective recruitment, hiring, development and training processes.

As more schools receive funding for technology, especially through literacy initiatives that help provide ebooks and devices, and as new platforms for digital comics and digital graphic novels open up, this medium stands to make a tremendous impact.

We are proud to, once again, fund the development of innovative technology that will directly impact the lives of pets in need,» said Susanne Kogut, Executive Director of the Petco Foundation.

While technology has revolutionized how comics can be funded, perhaps even more profound is its impact on how they reach their audiences.

New institutions include a Green Climate Fund to provide support for developing nations, a new technology initiative and a framework designed to improve communication in the international community and to protect developing countries from the impacts associated with climate change.

This analytical report gives an assessment of the current state of affairs with regard to the impact on the transport sector in developing countries by the Clean Development Mechanism (CDM), Global Environment Facility (GEF) and the Clean Technology Fund (CTF).

Both programmes use ClimateCare's innovative revolving fund model, which enables low - income households to purchase this life - improving technology, and enables a longer term, systematic approach to providing support alongside positive environmental impacts.

Impact Assessment of Clean Technology Fund in Renewable Energy and Energy Efficiency Market in Turkey

Another good provision is the IMPACT Act, focused on clean technology manufacturing, but here again it is unclear whether it will be adequately funded.

Staff of local governments, research organisations and NGOs participating in the UN Habitat Cities and Climate Change Programme and in 2 CDKN - funded projects were trained on the potential impacts of urban agriculture and - forestry on climate change adaptation and mitigation, and on practical methods for monitoring them; climate - smart urban agriculture technologies; and the design and assessment of alternative strategies for the development of urban agriculture as part of city climate change strategies.

The fund, according to the White House, would go to research on the projected impacts of climate change, help communities prepare for climate change's effects and fund «breakthrough technologies and resilient infrastructure.»

Add to that the lack of a legal framework and insufficient regulatory oversight regarding the use of such technologies, and Peltier has little confidence that the Green Fund will have its intended impact.

She has also represented global strategic investors such as Shell Technology Ventures, TOTAL S.A. and Intel Capital, as well as nationally based venture funds and impact venture funds such as Imprint Venture Lab.

Held at Jumeirah Mina A'Salam, this two - day conference delves into the innovative possibilities of blockchain and disruptive technologies, provides an introduction to ICOs (the funding model behind some of the most extraordinary capital raises of 2017) and looks at the transformative impact of cryptocurrencies on the global financial landscape.

This session will briefly examine the 2009 releases of the federally funded reports for early literacy and mathematics, and the survey of technology use in the prekindergarten settings to develop a backdrop for understanding the impact and implications for early childhood professionals.

In the post below, Dr Chelsea Bond, a Senior Lecturer in the Oodgeroo Unit at Queensland University of Technology, looks at the impact of the cuts for the broader Indigenous community controlled sector and for her work with InalaWangarra in Queensland, and at the higher levels of scrutiny on funding for Indigenous organisations than mainstream operations.

CPD 101: Business Enterprise Valuation CPD 102: Valuation of Property Impairments and Contamination CPD 103: Agricultural Valuation CPD 104: Hotel Valuation CPD 105: Highest and Best Use Analysis CPD 106: Multi-Family Property Valuation CPD 107: Office Property Valuation CPD 108: Seniors Facilities Valuation CPD 109: Lease Analysis CPD 110: Creative Critical Thinking: Advancing Appraisal to Strategic Advising CPD 111: Decision Analysis: Making Better Real Property Decisions CPD 112: Real Estate Consulting: Forecasting CPD 113: Request for Proposals (RFPs) CPD 114: Valuation for Financial Reporting - Real Property Appraisal and IFRS CPD 115: Appraisal Review CPD 116: Land Valuation CPD 117: Exposure & Marketing Time: Valuation Impacts CPD 118: Machinery and Equipment Valuation CPD 119: Urban Infrastructure Policies CPD 120: Urban Infrastructure Applications CPD 121: Submerged Land Valuation CPD 122: Expropriation Valuation CPD 123: Adjustment Support in the Direct Comparison Approach CPD 124: Residential Appraisal: Challenges and Opportunities CPD 125: Green Value — Valuing Sustainable Commercial Buildings CPD 126: Getting to Green — Energy Efficient and Sustainable Housing CPD 127: More Than Just Assessment Appeals — The Business of Property Tax Consulting CPD 128: Retail Property Valuation CPD 129: Industrial Property Valuation CPD 130: Residential Valuation Basics CPD 131: Commercial Valuation Basics CPD 132: More than Just Form - Filling: Creating Professional Residential Appraisal Reports CPD 133: Valuing Residential Condominiums CPD 134: Rural and Remote Property Valuation CPD 135: Buy Smart: Commercial Property Acquisition CPD 136: Waterfront Residential Property Valuation (Coming soon: 2018) CPD 140: Statistics 101: Math Literacy for Real Estate Professionals CPD 141: Exploratory Data Analysis: Next Generation Appraisal Techniques CPD 142: Introduction to Multiple Regression Analysis in Real Estate CPD 143: Appraisal Valuation Models CPD 144: Geographic Information Systems and Real Estate CPD 145: Introduction to Reserve Fund Planning CPD 150: Real Property Law Basics CPD 151: Real Estate Finance Basics CPD 152: Financial Analysis with Excel CPD 153: Entrepreneurship and Small Business Development CPD 154: Business Strategy: Managing a Profitable Real Estate Business CPD 156: Organizing and Financing a Real Estate Business CPD 155: Succession Planning for Real Estate Professionals CPD 157: Accounting and Taxation Considerations for a Real Estate Business CPD 158: Marketing and Technology Considerations for a Real Estate Business CPD 159: Human Resources Management Considerations in Real Estate (Coming Soon: 2018) CPD 160: Law and Ethical Considerations in Real Estate Business (Coming Soon: 2018) CPD 891: Fundamentals of Reserve Fund Planning CPD 899: Reserve Fund Planning Guided Case Study